Cytokinetics, Inc. Announces Second Extension of Research Term Under Collaboration With GlaxoSmithKline

SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Jun 19, 2007 -- Cytokinetics, Incorporated (NasdaqGM:CYTK - News) announced that it has agreed to extend the research term under its strategic alliance with GlaxoSmithKline (GSK) to continue research activities focused towards the mitotic kinesin centromere-associated protein E (CENP-E). The strategic alliance, initiated in June 2001, included an initial five-year research term. In June 2006, Cytokinetics and GSK announced a one-year extension to the research collaboration focused to translational research directed towards CENP-E. The companies have now agreed to extend the research program for an additional year, during which each company, at its own expense, will continue to perform translational research in accordance with an agreed plan.

MORE ON THIS TOPIC